Contacted by heartwire for comment on their publications, both Cuffe and Young noted that these two papers represent a step forward in the treatment of decompensated heart failure, not just because of ...

Feb. 24, 2003 — Milrinone significantly reduced the development of low output cardiac syndrome (LCOS) in children undergoing corrective surgery for congenital heart disease, according to the results ...

Cardiogenic shock is associated with substantial morbidity and mortality. Although inotropic support is a mainstay of medical therapy for cardiogenic shock, little evidence exists to guide the ...

Learn everything you need to know about Milrinone-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

Please provide your email address to receive an email when new articles are posted on . Among patients with cardiogenic shock, there was no difference between the inotropic agents milrinone and ...

A head-to-head comparison of inotropes in the setting of cardiogenic shock revealed no clear victor, with milrinone and dobutamine providing similar outcomes in the randomized DOREMI trial. A ...

Please provide your email address to receive an email when new articles are posted on . In the CAPITAL Do-Re-Mi trial, there was no difference in outcomes in patients treated with the widely used ...

Review the side-effects of Milrinone as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...